JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M200302200 on May 9, 2002

J. Biol. Chem., Vol. 277, Issue 30, 27294-27304, July 26, 2002
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
277/30/27294    most recent
M200302200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Amieux, P. S.
Right arrow Articles by McKnight, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Amieux, P. S.
Right arrow Articles by McKnight, G. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Increased Basal cAMP-dependent Protein Kinase Activity Inhibits the Formation of Mesoderm-derived Structures in the Developing Mouse Embryo*

Paul S. AmieuxDagger , Douglas G. HoweDagger , Heidi KnickerbockerDagger , David C. Lee, Thomas SuDagger , George S. LaszloDagger , Rejean L. Idzerda||, and G. Stanley McKnightDagger §

From the Dagger  Department of Pharmacology and the || Department of Medicine, University of Washington, Seattle, Washington 98195 and the  Department of Biochemistry, University of North Carolina, Chapel Hill, North Carolina 27599

Received for publication, January 10, 2002, and in revised form, April 19, 2002

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A targeted disruption of the RIalpha isoform of protein kinase A (PKA) was created by using homologous recombination in embryonic stem cells. Unlike the other regulatory and catalytic subunits of PKA, RIalpha is the only isoform that is essential for early embryonic development. RIalpha homozygous mutant embryos fail to develop a functional heart tube at E8.5 and are resorbed at approximately E10.5. Mutant embryos show significant growth retardation and developmental delay compared with wild type littermates from E7.5 to E10.5. The anterior-posterior axis of RIalpha mutants is well developed, with a prominent head structure but a reduced trunk. PKA activity measurements reveal an increased basal PKA activity in these embryos. Brachyury mRNA expression in the primitive streak of RIalpha mutants is significantly reduced, consistent with later deficits in axial, paraxial, and lateral plate mesodermal derivatives. This defect in the production and migration of mesoderm can be completely rescued by crossing RIalpha mutants to mice carrying a targeted disruption in the Calpha catalytic subunit, demonstrating that unregulated PKA activity rather than a specific loss of RIalpha is responsible for the phenotype. Primary embryonic fibroblasts from RIalpha mutant embryos display an abnormal cytoskeleton and an altered ability to migrate in cell culture. Our results demonstrate that unregulated PKA activity negatively affects growth factor-mediated mesoderm formation during early mouse development.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The cAMP-dependent protein kinase (PKA)1 is a multisubstrate serine/threonine protein kinase responsible for modulating a vast number of cell physiological processes ranging from the maintenance of basal transcription of specific genes (1, 2) to rapid reorganization of the cytoskeleton (3, 4). The mechanism by which PKA modulates cellular physiology is by covalent modification of polypeptide substrates via reversible enzymatic transfer of a phosphate moiety to a consensus phosphorylation motif in the target protein (5). The number and range of protein substrates phosphorylated by PKA is as varied as the cell physiological processes which it is known to regulate. These substrates occur in all cellular compartments, including the nucleus, cytoplasm, and plasma membrane (6).

The PKA holoenzyme is a heterotetramer composed of two N-terminally dimerized regulatory (R) subunits combined with two catalytic (C) subunits (5). PKA is unique in that the regulatory domain of the enzyme is encoded by separate genes located on different chromosomes. PKA is also unique in that the mechanism of activation involves simple subunit dissociation upon binding of cAMP to the regulatory subunits, thereby liberating catalytically active C subunits that diffuse throughout the cell, phosphorylating protein substrates containing appropriate consensus phosphorylation motifs.

Four regulatory (RIalpha , RIIalpha , RIbeta , and RIIbeta ) and two catalytic (Calpha and Cbeta ) isoform genes have been described in the mouse (7). Messenger RNA and protein for the alpha  isoforms of PKA (RIalpha , RIIalpha , and Calpha ) are found ubiquitously in the mouse and are expressed during early embryogenesis, whereas the beta  isoforms (RIbeta , RIIbeta , and Cbeta ) have more tissue-specific patterns of expression. RIbeta expression is restricted to neurons, whereas RIIbeta expression is highest in brain and brown and white adipose tissues (8, 9). Expression of Cbeta is highest in brain with lower levels in all tissues (10). The pattern of expression of R and C isoforms has been examined at day 14 of embryogenesis in the mouse (11). However, a more detailed study of the expression and function of PKA isoforms during early stages of mammalian development is lacking.

The cAMP/PKA signaling system is likely to play an important role in early development, and several lines of experimentation have suggested important pathways that are modified by PKA activity. A potential requirement for PKA activity in the regulation of zygotic gene activation in the preimplantation mouse embryo has been documented (12, 13). Studies of Drosophila imaginal disks demonstrate that imaginal disk cells lacking PKA activity behave as if they have received an excessive sonic hedgehog signal, resulting in dramatic pattern re-specifications (14-18). These observations led to the hypothesis that PKA acts to antagonize sonic hedgehog signaling and thus repress hedgehog-responsive genes such as decapentaplegic, patched, and wingless. By using constitutively active and dominant negative forms of PKA, two independent studies have shown that PKA acts as a common negative regulator of sonic hedgehog signaling in the zebrafish embryo (19-21). Apart from the role of PKA as a general negative regulator of sonic hedgehog signaling, research to date has not uncovered any other specific roles for PKA in vertebrate development. One recent report (22) has implicated PKA in even earlier stages of vertebrate embryogenesis. In this study it was demonstrated that dissociated zebrafish blastula cells required PKA activity for activin induction of the early mesoderm marker genes goosecoid and no tail. However, only mild effects were observed in vivo by injection of a dominant negative regulatory subunit of PKA on goosecoid and no tail expression. Furthermore, when Joore et al. (22) injected 2-4 cell stage zebrafish embryos with a constitutively active form of the catalytic subunit of PKA, it had no effect. This is in direct contrast to injections of a similar construct into 2-4 cell stage zebrafish embryos made by Hammerschmidt and McMahon (20), who observed that blastula stage zebrafish embryos were exquisitely sensitive to a constitutively active form of the catalytic subunit of PKA, resulting in failure of a large fraction of these embryos. Recent evidence in our laboratory has confirmed the sensitivity of vertebrate embryos to a constitutively active form of PKA catalytic subunit.2 In this study we present evidence that increased basal PKA activity resulting from targeted disruption of the RIalpha isoform of PKA affects signaling in the primitive streak, causing profound deficits in the production of all mesoderm derivatives including the heart.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Mapping the RIalpha Gene-- The mouse RIalpha genomic sequences were isolated from a Charon 4A lambda  phage library containing partial HaeIII/AluI fragments of BALB/c mouse genomic DNA. The promoter sites for the mouse RIalpha gene were determined by primer extension and S1 nuclease mapping.

RIalpha REC3 Targeting Vector-- In order to make a targeted disruption in the RIalpha gene, a 5.0-kb genomic HindIII fragment was isolated from a 129svJ mouse lambda  phage library using plaque hybridization screening with a 514-bp XhoI-EcoRI [32P]cDNA probe from RIalpha . A genomic fragment was isolated that contains a 5' 3.2-kb intron, the 170-bp exon 3, and 1.5-kb of 3' sequence including exons 4 and 5. This genomic fragment was then subcloned into a pUC18 vector. The vector was linearized at the XhoI site in exon 3 corresponding to amino acid 77 in the RIalpha coding sequence. A neomycin resistance cassette containing the SV40 promoter, the neomycin phosphotransferase cDNA, and poly(A) sequence was blunt end-ligated into the XhoI site. A thymidine kinase cassette containing the HSVtk promoter, the thymidine kinase cDNA, and poly(A) sequence was inserted 5' to the genomic sequence using EcoRI and BamHI sites in the pUC18 polylinker. This replacement type targeting vector was designated RIalpha REC3 and was linearized at the BamHI site before electroporation into ES cells.

Transfection of ES Cells and Generation of Germ Line Chimeras-- The generation of germ line-competent ES cells in our laboratory has been described (23). REK2 or REK3 ES cells were electroporated with 25 µg of BamHI-linearized RIalpha REC3 per 107 cells using a ProgenitorTM II PG200 electroporator (Hoefer Scientific Instruments) and subsequently grown under double selection in G418 (280 µg/ml) and ganciclovir (2 µM). DNA from ES cell clones was analyzed by Southern blot using a 1-kb SacI/HindIII RIalpha genomic probe located 3' to the targeting construct. Positively targeted clones were expanded and injected into C57BL/6 blastocysts that were subsequently implanted into BL6/CBAF1 pseudopregnant females. The resulting male chimeras were mated with C57BL/6 females, and agouti offspring were genotyped by Southern blot analysis. Both REK2- and REK3-derived male chimeras passed the mutation through the germ line resulting in heterozygous agouti offspring. Heterozygous agouti mice were then interbred and thus maintained on the mixed (129svJ × C57BL/6) background for all subsequent analyses.

Generation of RIalpha +/-Calpha +/- Animals for Interbreeding-- Targeting of the Calpha gene and creation of Calpha null mutant mice are the subject of a separate study (24). In order to generate RIalpha +/-Calpha +/- mice, RIalpha heterozygous female mice were crossed to Calpha heterozygous male mice, which are both on the 129svJ-C57BL/6 mixed background. Genotyping of offspring for RIalpha was carried out using the Southern blot strategy described above. Genotyping of offspring for Calpha was carried out using a Southern blot strategy in which a 315-bp HindIII/EcoRI probe located outside the Calpha targeting construct was hybridized to BamHI-digested genomic tail DNA. The targeted Calpha allele yields a 1.4-kb band, whereas the wild type allele yields a 4.1-kb band.

PCR Analysis of Yolk Sac DNA-- Individual yolk sacs were dissected away from the embryos in M2 media (Sigma) and transferred to 1× SET buffer (10 mM Tris, pH 7.4, 1 mM EDTA, 1% SDS) followed by overnight digestion with 300 µg/ml proteinase K in a 45 °C water bath. Yolk sac DNA was then extracted twice with phenol/chloroform and precipitated. DNA was resuspended in a total volume of 25 and 1 µl of the resuspended yolk sac DNA was used for PCR analysis with TaqDNA polymerase (PEC) using the following oligos at 1 µM final concentration: (A) RIalpha 5' exon 3, 5'-GAGGAGGCAAGACAGAT-3'; (B) RIalpha 3' exon 3, 5'-CTTTCTAACGTAGGAGG-3'; (C) Neo 5'-oligo, 5'-TCGCATGATTGAACAAG-3'; (D) Neo 3'-oligo, 5'-AAGCACGAGGAAGCGGT-3'. Reaction conditions for RIalpha exon 3 oligos were 94 °C for 1 min, 45 °C for 1 min, and 72 °C for 1.5 min for 35 cycles. Reaction conditions for the neomycin oligos were 94 °C for 1 min, 50 °C for 1 min, and 72 °C for 1.5 min for 35 cycles. Reaction conditions were optimized using the PCR OptimizerTM Kit (Invitrogen). In order to genotype embryos from RIalpha +/-/Calpha +/- × RIalpha +/-/Calpha +/- intercrosses, yolk sac DNA was isolated as described above, and the following two sets of Calpha -specific primers were used to genotype for Calpha : (A) Calpha 5' exon 6, 5'-CTGACCTTTGAGTATCTGCAC-3'; (B) Calpha 3' exon 7, 5'-GTCCCACACAAGGTCCAAGTA-3'; (C) Neo 5'-oligo, 5'-GTGGTTTGTCCAAACTCATCAATGT-3'; (D) Calpha 3' intron 7, 5'-AGACTACTGCTCTATCACTGA-3'. Reaction conditions for the Calpha exon 6 and 7 oligos were 94 °C for 30 s, 62 °C for 30 s, and 72 °C for 30 s for 30 cycles. Reaction conditions for the Neo and Calpha intron 7 oligos were 94 °C for 30 s, 62 °C for 30 s, and 72 °C for 1 min for 30 cycles.

Western Analysis and Kinase Assays-- For Western analysis only, E8.5 embryos were isolated in M2 media, rinsed through several changes of ice-cold PBS, and placed directly into 20 µl of 1× Laemmli sample buffer and boiled for 5 min. Lysates were loaded directly onto 10% SDS-PAGE gels and subsequently transferred to nitrocellulose membranes. Blots were blocked overnight, probed with an affinity-purified polyclonal antibody to RIalpha , and visualized using the Amersham Biosciences ECLTM system. Kinase assays were performed as described previously (8). Briefly, E8.5 embryos were isolated in M2 media, rinsed through several changes of ice-cold PBS, and subsequently homogenized on ice in 150 µl of lysis buffer (20 mM Tris, pH 7.5, 250 mM sucrose, 0.1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 10 mM dithiothreitol, 1 µg/ml leupeptin, 3 µg/ml aprotinin, 40 µg/ml soybean trypsin inhibitor, 0.5 mM 4-(2-aminoethyl)benzenesulfonyl fluoride) in a Dounce homogenizer followed by sonication using a Branson Sonifier 250 (5 pulses: output 3, duty cycle 50%). Homogenates were then snap-frozen and stored at -80 °C. Homogenates were thawed on wet ice and kinase assays performed in triplicate in the presence and absence of 5 µM cAMP with Leu-Arg-Arg-Ala-Ser-Leu-Gly (Kemptide) as the substrate. Assays were also performed in the presence of 40 µg/ml protein kinase inhibitor peptide-(5-24) to demonstrate that the kinase activity was PKA-specific (25). Bradford assays (Bio-Rad) were performed to determine protein concentration, and kinase activity was normalized to milligrams of protein.

HPLC Analysis-- HPLC analysis of RIalpha wild type and knockout E8.5 primary embryonic fibroblasts was performed as described (26). Briefly, fibroblasts were grown on gelatin-coated 60-mm dishes in 10% FBS/DMEM and incubated in a 5% CO2 incubator at 37 °C. Cells were lysed in homogenization buffer and stored at -80 °C until the day of the assay. The sample was diluted with homogenization buffer to a final concentration of 1-2 mg/ml, loaded onto a DEAE/HPLC column, and eluted using a linear salt gradient from 0 to 250 mM. Immediately following the HPLC separation, fractions were collected and assayed for kinase activity in the presence and absence of 5 µM cAMP with Kemptide as a substrate (8).

Histology-- Embryos were isolated in M2 media and fixed in Methacarnoys fixative (3:1.5:0.5 methanol/chloroform/glacial acetic acid) at room temperature. After fixation, embryos were processed through methanol (3 times for 15 min), methyl benzoate (1 times for 30 min), and xylenes (2 times for 15 min) and embedded in paraffin. Paraffin blocks were sectioned at 8 µm on a Reichert-Jung microtome, and histological sections were stained with hematoxylin and eosin. Sections were subsequently dehydrated through graded ethanols into xylenes and coverslipped with PermountTM. Embryo sections were photographed on a Nikon Microphot-FXA microscope.

Whole Mount in Situ Analysis-- Whole mount in situ analysis was performed as described (27). The following cRNA probes were generated as runoff transcripts using T3, T7, or SP6 RNA polymerase to generate sense and antisense probes: (A) Brachyury (gift from Virginia Papaioannou) linearized with BamHI (antisense) or HindIII (sense) and (B) Pax3 (gift from Peter Gruss) linearized with HindIII (antisense) or PstI (sense). Whole mounts were photographed on a Nikon SMZ-U Dissecting Scope.

Generation of Primary Embryonic Fibroblasts-- The derivation of primary embryonic fibroblasts has been described (28). Briefly, E8.5 mouse embryos were dissected out from the decidua, and all decidual tissues were removed from the yolk sacs, including Reichardt's membrane. Yolk sacs were removed from each individual embryo and kept for PCR analysis, and the amniotic membrane and allantois were removed and discarded. RIalpha mutant E8.5 embryos were easily identified by their morphology. Mutant or wild type embryos were pooled and placed in the tip of a 1-ml syringe in PBS and then triturated several times with a 20-gauge needle into a 96-well plate containing 10% FBS/DMEM and subsequently incubated in a 5% CO2 incubator at 37 °C. Primary embryonic fibroblasts were expanded from 96- to 24-well to 60-mm dishes over several weeks. The genotype of RIalpha mutant primary embryonic fibroblasts was confirmed by yolk sac PCR and Western analysis.

Cell Cycle Analysis Using Primary Embryonic Fibroblasts-- Analysis of cell cycle using DAPI staining has been described (29, 30). Briefly, subconfluent RIalpha mutant or wild type primary embryonic fibroblasts growing in 10% FBS/DMEM in 5% CO2 at 37 °C were gently trypsinized and subsequently washed twice through PBS and resuspended in 200 µl of buffer containing 4,6-diamino-2-phenylindole (10 µg/ml DAPI, 0.1% Nonidet P-40, 20 mM Tris, pH 7.5, 150 mM NaCl). The suspensions were triturated with a 26-gauge needle and analyzed using a Coulter ELITE cytometer with ultraviolet excitation and DAPI emission collected at >450 nm. DNA content and cell cycle were analyzed using the software program Multicycle.

In Vitro Migration Assay Using Primary Embryonic Fibroblasts-- Wild type and RIalpha mutant primary embryonic fibroblasts were seeded onto sterile glass coverslips in 12-well tissue culture dishes in 10% FBS/DMEM and grown to confluency in a 5% CO2 incubator at 37 °C. By using a p200 pipette tip, a wound was incised across the central area of the coverslip, and a line perpendicular to the incision was made on the bottom of the 12-well plate to mark the location for image collection. Images were collected at 4-h intervals using a Leica inverted scope interfaced with a Kodak 290 Digital camera and the Kodak Capture DC290 software.

Confocal Imaging of Fibroblasts-- For actin cytoskeletal visualization, fibroblasts grown in 10% FBS/DMEM at 37 °C in a 5% CO2 incubator were seeded onto 1% gelatin-coated coverslips in 12-well plates. At the time of staining, cells were fixed with 4% paraformaldehyde in PBS for 20 min, washed, delipidated with PBS containing 1% Triton X-100 for 5 min, washed, blocked with 1% bovine serum albumin in PBS for 20 min, and subsequently stained for 20 min with Texas Red phalloidin (Amersham Biosciences). After staining, cells were washed again and coverslipped in phosphate-buffered glycerol containing m-phenylenediamine (Sigma) to counterstain the nuclei. Slides were imaged using a Bio-Rad MRC 600 confocal microscope using standard excitation filters for Texas Red and fluorescein isothiocyanate labels. For RIalpha and Calpha visualization, wild type and RIalpha knockout fibroblasts were seeded onto gelatin-coated coverslips in 12-well plates as above. Cells were fixed in 4% paraformaldehyde at room temperature and then blocked in a 2% biotin solution, a 2% avidin solution, and 10% normal goat serum, Tris-buffered saline, 0.015% Triton X-100 at 4 °C overnight. The following day cells were incubated in a 1:500 dilution of either rabbit polyclonal anti-Calpha or rabbit polyclonal anti-RIalpha in 10% normal goat serum, Tris-buffered saline, 0.015% Triton X-100 overnight at 4 °C. The next day cells were washed, incubated in a 1:300 dilution of biotinylated goat anti-rabbit antibody for 2 h, followed by a 1:300 dilution of avidin-fluorescein for 2 h. Cells were washed a final time and coverslipped with vectashield containing 1.5 µM propidium iodide to visualize nuclei. Staining was visualized as mentioned above using the Bio-Rad MRC600 confocal microscope using the Texas Red filter for nuclei and the fluorescein isothiocyanate filter for Calpha or RIalpha .

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Structure of the Mouse RIalpha Gene-- Mapping and sequencing of lambda  clones generated a map of the RIalpha locus showing that the gene contains 11 exons and spans about 18 kb in the mouse genome. The position of intronic sequences within the coding region corresponds to the genomic structure of the closely related mouse RIbeta gene (31). A previous mapping of the human RIalpha gene showed only 10 exons (32), but a recent report demonstrates 11 exons (33) indicating conservation between the human and mouse RIalpha genes. The promoter site for the mouse RIalpha gene was mapped by primer extension and S1 mapping and revealed multiple start sites within a GC-rich 5'-flanking region with no recognizable TATA or CCAAT box homologies. This promoter and first non-coding exon corresponds to promoter 1a as characterized for the human RIalpha gene. Other promoter regions are used in humans (32) but all of these first exons are non-coding and splice to the first coding exon, exon 2, to give identical protein products. Fig. 1A shows a diagram of the mouse RIalpha gene and the overlapping lambda  clones that were analyzed, and Fig. 1B contains the sequence of the exons and exon/intron boundaries as well as the sequence of the 1a promoter region.


View larger version (56K):
[in this window]
[in a new window]
 
Fig. 1.   Structure of the RIalpha gene. A, genomic map of the RIalpha gene locus showing the location of the 11 exons and the Charon 4A lambda  phage clones used for the analysis of the RIalpha locus. B, sequence of the RIalpha promoter and exons with positions of introns and intron/exon boundary sequences shown. The region boxed in from nucleotides 171 to 223 contained multiple transcriptional start sites. Poly(A) addition signals are underlined in the 3'-untranslated region.

Targeting the RIalpha Gene in Mice Results in Increased Basal PKA Activity-- In order to address the role of the RIalpha isoform of PKA in mouse development, we generated a targeted disruption of the gene. The targeting vector, RIalpha REK3, contained a neomycin resistance cassette inserted into exon 3 of a 5-kb 129svJ genomic fragment of the RIalpha gene (Fig. 2A) and a thymidine kinase cassette flanking the RIalpha genomic coding sequence. This targeting vector was electroporated into REK2 and REK3 ES cell lines (34), and Southern blot analysis identified clones from both REK2 and REK3 ES cells that had homologously recombined the replacement vector sequence into the RIalpha gene (Fig. 2B). The targeting efficiency observed for the construct over several electroporations was ~1 in 30. Targeted REK2 and REK3 ES cell lines were injected into C57BL/6 blastocysts, and the resulting male chimeric offspring were bred to C57BL/6 females. Chimeras generated from the two independently derived targeted ES cell lines transmitted the mutation through the germ line. The analysis of RIalpha mutant embryos in this study are derived from mice generated from REK2- and REK3-targeted ES cell clones on the mixed (129svJ × C57BL/6) background.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 2.   Targeted disruption of the RIalpha gene. A, schematic representation of the targeting scheme. The top line shows a restriction map of a 5-kb segment of the RIalpha genomic coding sequence containing exons 3-5 that was subcloned into Bluescript KS+. The middle line shows a schematic representation of the targeting construct that has a neomycin resistance cassette subcloned into the XhoI site of exon 3. No genomic coding sequence was removed in the targeting vector. A Southern blot of EcoRV-digested genomic DNA using the 3' SacI/HindIII genomic probe indicated on the right of the targeting vector produces a 5.5-kb fragment for the wild type allele and a 7.5-kb band for the targeted allele. RIalpha exon 3 oligos (black arrowheads) and neomycin oligos (white arrowheads) used for PCR genotyping of yolk sac DNA are indicated by arrowheads. A thymidine kinase resistance cassette was subcloned into the multiple cloning site at the 5' end of the genomic sequence in the targeting vector to select against random integrations. The bottom line shows the targeted locus in the RIalpha gene that contains the neomycin cassette inserted into exon 3. B, EcoRV-digested genomic tail blots of agouti offspring obtained from breeding high percentage RIalpha male chimeras to C57BL/6 females. The blot was probed with the SacI/HindIII genomic probe indicated above. As expected, heterozygous agouti offspring show a 5.5- and a 7.5-kb band indicating that the targeted RIalpha allele has been transmitted through the germ line of RIalpha male chimeras. C, PCR analysis using the yolk sac DNA of embryos obtained from interbreeding RIalpha heterozygous male and female offspring. The oligos used for PCR analysis in the top panel correspond to the 5' and 3' end of RIalpha exon 3 and should yield a 171-bp product if the wild type allele is present. RIalpha homozygous mutant embryos lack this 171-bp product consistent with the disruption of exon 3 by insertion of the neomycin cassette into both alleles of the RIalpha gene. In a separate reaction shown in the bottom panel, 5'- and 3'-oligonucleotides internal to the neomycin resistance cassette were used which yield a 550-bp product if the neomycin cassette is present and no product in wild type animals. D, 10 µg of total protein from wild type and mutant homogenates used in the kinase assays was run on an SDS-PAGE gel and transferred to nitrocellulose. The blot was subsequently probed with an affinity-purified polyclonal antibody to RIalpha . nt, nucleotide.

Mice carrying a heterozygous mutation in RIalpha were viable, fertile, and morphologically indistinguishable from wild type littermates; however, interbreeding of RIalpha heterozygotes to generate RIalpha homozygotes resulted only in wild type and heterozygous offspring in a 1:2 ratio. To determine the point at which RIalpha homozygous embryos were no longer viable, embryos from heterozygous intercross matings were analyzed at successive stages of development. Only resorption sites were found upon initial inspection of embryos at E11.5; however, RIalpha mutant embryos were found in Mendelian ratios from E7.5 up to E10.5 (Table I). PCR genotyping of yolk sac DNA using 5'- and 3'-oligonucleotides to RIalpha exon 3 confirmed that the mutant embryos do indeed carry the disruption in exon 3 (Fig. 2C). To confirm the absence of RIalpha protein in homozygous mutant embryos, mutant and wild type or heterozygote embryos were homogenized directly in sample buffer and run on an SDS-PAGE gel followed by probing with an affinity-purified polyclonal antibody to RIalpha (Fig. 2D). Western blot analysis confirms that RIalpha protein is indeed absent in the phenotypically mutant embryos.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Distribution of genotypes in embryos and adult mice from RIalpha heterozygous matings

To determine whether loss of the RIalpha regulatory subunit results in increased or decreased PKA activity, we performed kinase assays on pooled E8.5 mutant and wild type or heterozygote embryos (Fig. 3E). Although the total PKA activity is decreased by ~40%, basal PKA activity is increased substantially in RIalpha mutant embryos. The reduction in total PKA activity in the absence of the RIalpha subunit is consistent with previous research in cell culture that has demonstrated that the PKA catalytic subunit is unstable when not complexed to regulatory subunits (35), suggesting that there is an increase in free C subunit in RIalpha mutant embryos that is also more rapidly degraded. Approximately 52% of the kinase activity in RIalpha mutant embryos is still cAMP-regulated, and Western blots confirm the presence of RIIalpha in RIalpha mutant embryos (Fig. 3E, inset). Interestingly, up-regulation of RIIalpha is not observed in RIalpha mutants, which is consistent with observations made in cell culture where PKA catalytic subunit was overexpressed (35). In fact, a decrease in RIIalpha levels is seen in the RIalpha knockout embryos that is also observed in primary embryonic fibroblasts isolated from these embryos (Fig. 7B, inset).


View larger version (78K):
[in this window]
[in a new window]
 
Fig. 3.   RIalpha mutant embryos are severely growth-retarded and have increased basal PKA activity. A, morphology of E7.5 wild type and RIalpha mutant embryos. Mutant embryos are smaller than wild type littermates but have a well formed A-P axis, including head-folds, node, and allantois. B, morphology of E8.5 wild type and RIalpha mutant embryos. Mutant embryos show severe growth retardation and developmental delay resembling presomite head-fold stage embryos. The cardiogenic plate is present but no heart tube has formed. C, morphology of E9.5 wild type and RIalpha mutant embryos. E9.5 mutant embryos are severely growth-retarded, have failed to form a contractile heart tube, and have not initiated the turning process. D, comparison of an E9.5 RIalpha mutant embryo with wild type embryos from several stages of development. Mutant embryos at E9.5 resemble E8.0 wild type embryos. Although RIalpha mutants are approximately the same size as E8.0 wild type embryos, mutants differ in that they have more somites, an allantois that is thickened at the base, a more radical entry of the foregut, and bilateral cardiocytes that have failed to fuse ventrally to form the heart. Scale bars in A-D = 500 µM. The abbreviations used are as follows: al, allantois; cp, cardiogenic plate; fg, foregut; hp, head process; ht, heart; nd, node; tr, trunk; ys, yolk sac. E, basal and total kinase activity in E8.5 wild type (WT) and RIalpha mutant embryos. KO, knockout. Mutant (n = 2) and wild type (n = 4) embryos were pooled after removal of yolk sacs for PCR genotyping and homogenized in kinase assay buffer. Kinase assays were performed in triplicate in the presence and absence of cAMP using Kemptide as the substrate. Homogenates were also assayed in the presence of protein kinase inhibitor to demonstrate that the measured kinase activity was PKA-specific. Inset, Western analysis using polyclonal antibodies to RIalpha or RIIalpha from homogenates used for kinase assays.

Phenotype of RIalpha Mutant Embryos-- One of the most striking features of RIalpha mutant embryos when first observed was severe growth retardation combined with developmental delay. Although not morphologically evident in mid- and late-streak stage embryos, the phenotype became clearly apparent from the head-fold stage forward (Fig. 3B). Examination of over 30 RIalpha mutant embryos at E9.5 revealed a very consistent mutant phenotype. The anterior-posterior axis of RIalpha mutant embryos is clearly apparent, with a prominent head structure followed by a greatly reduced trunk structure compared with wild type E9.5 littermates (Fig. 3C and Fig. 4, A and B). The E9.5 RIalpha mutant embryo is equivalent in size to an E8.0 wild type embryo (Fig. 3D). The most striking feature of the RIalpha E9.5 mutant embryo when compared with an equivalently sized E8.0 wild type embryo is the absence of a definitive heart tube (Fig. 3, B and D). The cardiogenic plate is present (Fig. 3B), but rather than being displaced more caudally by the formation of the heart tube, it is tightly juxtaposed to the proencephalon. The absence of a heart tube also results in a more radical angle of entry of the foregut (Fig. 3D).

At E8.5, RIalpha mutant embryos can be easily recognized by their small size, flattened morphology (Fig. 3B), and ruffled yolk sac membrane (not shown). Mutant embryos at this stage resemble presomite head-fold stage wild type embryos and are situated appropriately within the yolk sac and amniotic membranes. At E7.5 the developmental delay is less apparent, although E7.5 RIalpha mutant embryos are smaller than wild type littermates and have the characteristic flattened appearance and ruffling of the yolk sac membrane.

Abnormal Cardiac Morphogenesis in RIalpha Mutant Embryos-- As mentioned in the previous section, although the cardiogenic plate is present in E8.5 mutant embryos, no heart tube is formed. Morphological and histological examination of the cardiogenic plate reveals the presence of bilateral cardiocytes located within the putative intraembryonic coelomic cavities that have failed to fuse and thus form the pericardial cavity (Fig. 4, C and D). Examination of one E11.5 litter containing three RIalpha mutant embryos revealed the presence of bilaterally located cardiocytes within enlarged coelomic cavities that contracted rhythmically at room temperature in M2 media at 36 beats/min for several hours (not shown). Histological examination of these embryos revealed the presence of healthy bilateral aggregations of cardiocytes, whereas the embryos themselves were completely necrosed. These observations support the conclusion that at least some mesodermal cells arising from the posterior epiblast of RIalpha mutants have ingressed through the primitive streak and migrated in the appropriate lateral and anterior direction together with the definitive endoderm to arrive at the heart field (36). Interestingly, the RIalpha mutants never initiate the turning process that would normally occur at the 7-8 somite transition (37). The absence of turning is also evident in the BMP 2 and GATA 4 knockouts that display aberrant cardiac morphogenesis (38, 39). In the case of BMP 2, a failure in the closure of the proamniotic canal results in the formation of a single heart tube outside the amniotic membrane (39). In the GATA 4 knockout, a failure of lateral to ventral folding results in the formation of fully developed bilateral heart tubes located dorsal to the aberrant foregut (38). In the RIalpha mutants, we hypothesize that the failure of the bilateral cardiocytes to fuse ventrally arises from a deficiency in the total number of mesodermal cells fated to become cardiocytes.


View larger version (93K):
[in this window]
[in a new window]
 
Fig. 4.   RIalpha mutant embryos have deficiencies in cranial and trunk mesenchyme. A, scanning electron microscopy of the head of an E9.5 wild type embryo. Note the well developed forebrain, midbrain, and hindbrain resulting from complete closure of the neural tube. The first and second branchial arches are present and lie adjacent to the pericardium. The otic vesicle has delaminated from the surface ectoderm, and the optic vesicle is visible. B, scanning electron microscopy of the head of an E9.5 mutant embryo. Note the open neural tube in the forebrain and midbrain region. Branchial arches are absent, and cranial mesenchyme is severely deficient. The otic vesicle is present and has delaminated from the surface ectoderm. C, E8.5 wild type embryo showing ventral heart tube formation, including both endocardial and myocardial elements suspended within the pericardium and attached via the dorsal mesocardium. D, equivalent section through an E9.5 mutant embryo showing the absence of a ventral linear heart tube and pericardium. Precardiac mesoderm is present on either side of the midline of the pharynx. Note the persistence of the intraembryonic coelomic cavities that have failed to fuse and form the pericardium. E, whole mount in situ staining of an E9.5 RIalpha mutant and an E9.5 wild type embryo using a Pax 3 antisense riboprobe. Note the staining in the 10-12 tiny somites that lie adjacent to the neural tube. Somites in the RIalpha mutant are segmented but are greatly reduced in size and number when compared with the E9.5 wild type littermate. F, ventral view of E9.5 RIalpha mutant compared with an E9.5 RIalpha wild type littermate. Note the absence of fusion of somites across the midline, indicating the presence of notochord tissue. Scale bars in A-D = 100 µm; E and F = 500 µm. The abbreviations used are as follows: am, amnion; cm, cardiomyocytes; co, intraembryonic coelomic cavity; da, dorsal aorta; en, endocardium; fg, foregut; hp, head process; mc, myocardium; ng, neural groove; pcm, precardiac mesoderm; ph, pharynx; ysm, yolk sac membrane.

Axial and Paraxial Mesoderm Is Formed and Expresses Appropriate Markers but Is Greatly Reduced in Size-- As mentioned previously, the anterior-posterior axis of RIalpha mutant embryos is well defined, including axial and paraxial mesodermal derivatives. A morphological node is apparent in E7.5 mutant embryos (Fig. 3A), and the notochord is clearly present in rostral sections of E9.5 mutant embryos (not shown). Although paraxial mesoderm is formed and is segmented in RIalpha mutants, the somites are very small and irregularly shaped (Fig. 4, E and F). The absence of fusion of somites along the ventral midline suggests that notochord material must be present along the rostro-caudal axis of RIalpha mutants (Fig. 4F), as the complete absence of notochord normally results in ventral fusion of somites (40-42). Although the somites are small and irregularly shaped, they do express the dermomyotomal marker Pax 3, suggesting that dorsolateral differentiation of the somites is progressing normally (Fig. 4E).

Reduced Primitive Streak and Abnormal Migration of Mesoderm in RIalpha Mutants-- Due to the deficiencies observed in mesodermal derivatives, we chose to look at earlier stages of mesoderm formation in RIalpha mutant embryos. Histological examination of E6.5 RIalpha mutant embryos compared with E6.5 wild type littermates revealed aberrant migration of mesodermal cells away from the primitive streak. Although wild type late-streak stage embryos always exhibit very tightly ordered columns of mesodermal cells that extend smoothly in a lateral and anterior direction, the mutants display highly disorganized movement away from the primitive streak (Fig. 5, A and B). Quantitation of mesodermal cells that have exited the streak in the embryonic portion of late-streak stage RIalpha mutant embryos indicates that mutants have approximately one-third the number of mesodermal cells that have exited the streak and moved laterally and anteriorly (Fig. 5C). Reduction in primitive streak mesoderm is also clearly visible 2 days later in the E8.5 RIalpha mutant embryo, where a significant reduction in brachyury mRNA is observed (Fig. 5D). An accumulation of presumptive mesoderm beneath the primitive streak that has failed to migrate out laterally and anteriorly is observed in the E9.5 embryo (not shown).


View larger version (75K):
[in this window]
[in a new window]
 
Fig. 5.   Deficiencies in mesoderm formation begin at gastrulation. A, representative eosin-hematoxylin-stained 8-µm section through a wild type E6.5 late streak stage embryo. Note the thick and highly ordered columns of mesodermal cells that have exited the primitive streak and moved laterally and anteriorly. Inset, outline of the embryo showing the approximate location of the section. B, representative eosin-hematoxylin-stained 8-µm section through an RIalpha mutant late streak stage embryo. Note the reduced number of mesodermal cells that have exited the streak and the highly disorganized manner in which the cells have exited the streak to move anteriorly. Inset, outline of the embryo showing the approximate location of the section. C, quantitation of the number of mesodermal cells that have exited the streak in the embryonic portion of wild type (n = 2) and RIalpha mutant (n = 2) late-streak stage embryos. Data are the total number of mesodermal cells ± S.D. that have exited the streak from four representative 8-µm sections for each embryo. Sections were at the same level for each embryo. D, whole mount in situ staining of an E8.5 wild type and RIalpha mutant embryo using a brachyury antisense riboprobe. Note the greatly reduced staining in the primitive streak region as compared with the wild type embryo. Scale bars in A and B = 50 µm; D = 500 µm. The abbreviations used are as follows: ant, anterior; ect, ectoderm; end, endoderm; mes, mesoderm; pos, posterior; ps, primitive streak.

Loss of RIalpha Alters Cell Morphology, Migration, and Localization of C Subunit in Primary Embryonic Fibroblasts-- To address the hypothesis that increased PKA activity inhibits growth factor signaling involved in the proliferation and migration of mesoderm from the primitive streak stage forward, we isolated mesodermal primary embryonic fibroblasts from E8.5 RIalpha mutant and wild type embryos. Fibroblasts isolated from these embryos were extremely unusual with respect to overall morphology. Rather than showing the typical spindled morphology of wild type fibroblasts, RIalpha mutant fibroblasts are flattened and show a box-shaped or rounded morphology. Examination of the actin cytoskeleton revealed that the RIalpha mutant fibroblasts have multiple actin organizing centers that extend in all directions and an extensive subcortical actin cytoskeleton, whereas wild type fibroblasts display sparse parallel actin fibers running from the leading to the lagging edge of the cell (Fig. 6, A and B). To assess localization of C subunit, confocal imaging was used on wild type and RIalpha knockout E8.5 primary embryonic fibroblasts. C subunit is uniformly distributed throughout the cytoplasm of the wild type fibroblasts (Fig. 6C); however, in RIalpha knockout fibroblasts, C subunit was preferentially localized to the perinuclear space (Fig. 6D). Examination of RIalpha localization revealed a uniform cytoplasmic distribution in wild type fibroblasts (Fig. 6E), similar to that observed for Calpha , whereas no staining was observed in RIalpha knockout fibroblasts (Fig. 6F). Cell cycle analysis of wild type and RIalpha mutant fibroblasts showed no difference in the percentage of cells in G0/G1, S, and G2/M (Fig. 7A). cAMP activation curves revealed high basal PKA activity in RIalpha mutant fibroblasts consistent with the unregulated PKA activity observed in the RIalpha knockout embryos (Fig. 7B). A small decrease in total PKA activity was observed compared with wild type fibroblasts combined with a decrease in RIIalpha levels in RIalpha knockout fibroblasts (Fig. 7B, inset). HPLC analysis of wild type E8.5 primary embryonic fibroblasts reveals significant quantities of type II holoenzyme along with type I holoenzyme (Fig. 7C). Quantitation of the type II and type I holoenzyme peaks indicates a type II to type I ratio of ~3.5 to 1 in the wild type cells and as expected no type I kinase in the mutants (Fig. 7C).


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 6.   Confocal imaging of the actin-based cytoskeleton, Calpha , and RIalpha localization in E8.5 RIalpha knockout and wild type primary embryonic fibroblasts. Confocal image of Texas Red phalloidin-stained wild type E8.5 primary embryonic fibroblasts (A) and RIalpha mutant E8.5 primary embryonic fibroblasts (B). Fibroblasts were seeded onto glass coverslips in 12-well dishes, fixed, permeabilized, incubated with Texas Red phalloidin, and subsequently washed and coverslipped. The actin cytoskeleton (red) was visualized by confocal microscopy with appropriate filters. Nuclei were counterstained with m-phenylenediamine (green). Calpha staining of wild type E8.5 primary embryonic fibroblasts (C) and RIalpha knockout E8.5 primary embryonic fibroblasts (D) are shown. Cells were seeded onto glass coverslips in 12-well dishes, fixed, permeabilized, blocked, and incubated with a rabbit polyclonal antibody to Calpha followed by biotin anti-goat antibody and avidin-fluorescein. Calpha localization (green) and nuclei counterstained with propidium iodide (red) were visualized as above. RIalpha staining in wild type E8.5 primary embryonic fibroblasts (E) and RIalpha knockout E8.5 primary embryonic fibroblasts (F) are shown. Cells were treated exactly as in the Calpha staining, but a rabbit polyclonal antibody to RIalpha was used in lieu of the Calpha antibody. Scale bars = 100 µm.


View larger version (65K):
[in this window]
[in a new window]
 
Fig. 7.   Analysis of cell cycle parameters, kinase activity, holoenzyme assembly, and cell migration in RIalpha knockout (KO) and wild type (WT) E8.5 primary embryonic fibroblasts. A, cell cycle analysis of RIalpha mutant and wild type E8.5 primary embryonic fibroblasts. Fibroblasts grown in 60-mm dishes in 10% FBS/DMEM in 5% CO2 at 37 °C were washed, trypsinized, washed, and resuspended in 200 µl of DAPI buffer. Fibroblasts were subsequently run through a Coulter counter to measure the DAPI fluorescence over 20,000 cells. DNA histograms were subsequently analyzed for cell cycle parameters using the "multicycle" software package. B, cAMP activation curves with RIalpha wild type E8.5 primary embryonic fibroblasts and RIalpha knockout E8.5 primary embryonic fibroblasts. Cells in 60-mm dishes were washed and lysed in homogenization buffer, sonicated, and stored at -80 °C until the day of the assay. Samples were thawed and homogenates assayed in triplicate with various concentrations of cAMP using the standard kinase assay described under "Experimental Procedures." cAMP activation curves were performed three times with similar results. Inset, Western analysis from homogenates of wild type and RIalpha knockout primary embryonic fibroblasts using polyclonal antibodies to RIalpha or RIIalpha . C, kinase assays on fractions obtained by HPLC DEAE ion-exchange fractionation of homogenates from E8.5 wild type and RIalpha knockout primary embryonic fibroblasts. Cells were grown in 60-mm dishes, washed, lysed, sonicated, and stored at -80 °C until the day of the assay. On the day of the assay, 1-2 mg of protein homogenate was loaded on a 2-ml DEAE ion-exchange column and separated by HPLC into 1-ml fractions over a 0-250 mM salt gradient. Fractions were assayed the same day by kinase assay as described under "Experimental Procedures." D, in vitro wound assay monitoring the migration of RIalpha mutant and wild type fibroblasts. Fibroblasts were seeded onto glass coverslips in 12-well dishes and allowed to grow to confluency. An incision was made across the center of the coverslip using a p200 pipette tip; the media were replaced, and migration of fibroblasts back into the artificial wound was monitored using an Leica inverted scope interfaced with a Kodak DC290 digital camera and accompanying software. Magnification = ×100.

Migration assays using an in vitro wound model demonstrated that RIalpha mutant fibroblasts completed wound healing by ~18 h, whereas wild type fibroblasts were significantly slower at completing this process (Fig. 7D). This difference in migration and "wound healing" was similar when fibronectin-coated dishes were used in place of uncoated plastic. The significantly faster closure of a scrape "wound" in cell culture by RIalpha mutant fibroblasts is superficially at odds with the observed deficiency in mesoderm formation and migration out of the primitive streak in RIalpha knockout embryos. However, it is likely that the complex environment at the primitive streak in vivo, involving FGF-dependent receptor tyrosine kinase signaling, E cadherin down-regulation, epithelial to mesenchymal transition, and subsequent integrin-dependent migration of nascent mesoderm over the endoderm is not adequately modeled by this in vitro assay.

The Deficits in Mesodermal Derivatives Can Be Rescued by Crossing RIalpha Mutants to Calpha Mutants-- Based upon the hypothesis that the defects observed in the mesoderm of RIalpha mutants is a result of increased basal PKA activity, we attempted to rescue the RIalpha mutant phenotype by crossing RIalpha mutants to Calpha mutant mice that carry a null mutation in the Calpha gene (24). As Calpha homozygous mutant mice are infertile and RIalpha homozygous mutant mice are embryonic lethals, we generated RIalpha /Calpha double heterozygotes (RIalpha +/-/Calpha +/-) by crossing RIalpha heterozygous females to Calpha heterozygous males. The resulting RIalpha +/-/Calpha +/- double heterozygous animals were viable and were interbred to generate RIalpha knockout animals on the Calpha heterozygous and Calpha homozygous background. The first 32 offspring from a total of four litters yielded RIalpha -/-/Calpha +/- and RIalpha -/-/Calpha -/- offspring at the expected Mendelian ratios of 1:8 and 1:16. RIalpha -/-/Calpha +/- embryos were easily identified by their morphology and display an intermediate phenotype clearly indicative of partial rescue of the RIalpha mutation (Fig. 8C). One of the most dramatic features of RIalpha -/-/Calpha +/- is the presence of a definitive heart tube located within a fluid-filled pericardial cavity (Fig. 8C). Morphological and histological examination of these embryos reveals a significant increase in all axial, paraxial, and lateral plate mesodermal derivatives, including increased head mesenchyme, increased somite size and number, and increased trunk length. Unlike the RIalpha mutants, RIalpha -/-/Calpha +/- embryos also seem to have initiated the turning process (Fig. 8C). RIalpha -/-/Calpha -/- embryos showed an even greater degree of rescue compared with the RIalpha mutant phenotype (Fig. 8, B and D). RIalpha -/-/Calpha -/- shows dramatic increases in trunk length, somite number and size, branchial arch and limb bud development, and head mesenchyme. Unlike RIalpha mutants, RIalpha -/-/Calpha -/- also completes the turning process and has a heart tube located within the pericardial cavity (Fig. 8, B and D). Kinase activity measurements from the various genotypes revealed a predictable decrease in total PKA activity but also a graded decrease in basal PKA activity as Calpha alleles are deleted on the RIalpha knockout background (Fig. 8E). Genotyping of newborn pups from several RIalpha +/-/Calpha +/- interbreedings has failed to yield viable RIalpha knockout animals, suggesting that the lack of RIalpha protein on the Calpha knockout background is still lethal. Examination of RIalpha -/-/Calpha -/- embryos at midgestation (E10.5) revealed an expanded fluid-filled pericardial cavity, suggesting cardiovascular failure in the absence of RIalpha at a later stage in development.


View larger version (53K):
[in this window]
[in a new window]
 
Fig. 8.   RIalpha mutants can be rescued on the Calpha mutant background. Morphology of an E9.5 RIalpha +/+Calpha +/+ wild type littermate (A), E9.5 RIalpha -/-Calpha +/+ mutant (B), E9.5 RIalpha -/-Calpha +/- mutant (C), and an E9.5 RIalpha -/-Calpha -/- mutant (D). Scale bars = 500 µm. E, measurement of basal and total PKA activity from all four genotypes. Animals were staged and embryos collected from two litters (14 total embryos) to obtain rescued embryos with the genotypes indicated. Embryos were homogenized, sonicated, and stored at -80 °C until the day of the assay.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We have utilized targeted disruption of PKA subunit genes to determine the developmental and physiological roles of individual isoforms of the PKA family of genes in the mouse. Disruption of the RIIalpha subunit that is expressed ubiquitously at all stages of development did not lead to any developmental deficits, and the animals were healthy and fertile (43). However, in this report we show that disruption of the other ubiquitous R subunit, RIalpha , results in a dramatic developmental phenotype. This phenotype is characterized by mesodermal insufficiency, and the early manifestations are caused by inappropriately regulated C subunit activity because we can partially rescue the RIalpha mutant embryos by breeding them onto a Calpha knockout genotype that reduces the total level of C subunit in the mutants.

The observation that receptor-tyrosine kinases are critical for mesoderm formation combined with the substantial literature on PKA-dependent inhibition of receptor tyrosine kinase signaling led to the hypothesis that increased PKA activity in the RIalpha mutants might be antagonizing growth factor-dependent signaling in the primitive streak. This possibility is consistent with the greatly reduced brachyury whole mount in situ staining in the primitive streak of RIalpha mutants and the deficiencies in anterior mesoderm-derived structures. The accumulation of nascent mesoderm at the base of the primitive streak also suggests deficits in integrin-dependent cell migration over the endoderm which also depends upon growth factor receptor-tyrosine kinases and extracellular matrix signals (44). Targeted disruption in mice of several key proteins involved in integrin-mediated signaling and migration, including fibronectin and focal adhesion kinase (FAK), result in the failure of embryos at gastrulation (45-47). FAK-deficient and fibronectin-deficient embryos bear a striking resemblance to each other and to RIalpha mutant embryos, including growth retardation, developmental delay, failure of cardiac morphogenesis, and anterior mesoderm deficits. The similarities in the phenotypes of FAK, fibronectin, and RIalpha mutant embryos combined with the literature describing PKA-dependent regulation of the actin cytoskeleton support the hypothesis that growth factor/integrin signaling may be affected (3, 4). Activation of PKA causes dephosphorylation of paxillin via increasing a tyrosine phosphatase activity (48). More recent evidence demonstrates that PKA can phosphorylate and activate Shp2, a tyrosine phosphatase that localizes to focal adhesion complexes and dephosphorylates both paxillin and FAK (49, 50). Related studies reveal that the p21-activated kinases are also critical for the integration of growth factor and integrin-extracellular matrix signals with the actin cytoskeleton (51, 52). Significantly, PKA activity also negatively regulates p21-activated kinase and thus interferes with its ability to mediate anchorage-dependent growth factor responses (53). Isolation of primary embryonic fibroblasts from E8.5 RIalpha mutant embryos reveals a profound disruption of the actin-based cytoskeleton. These fibroblasts bear a striking resemblance to FAK-deficient and Shp2-deficient primary embryonic fibroblasts, including a dramatic increase in focal adhesions and condensed F-actin aggregation at the cell periphery (47, 54). Expression of a dominant negative Shp2 tyrosine phosphatase prevents paxillin and FAK dephosphorylation and results again in increased focal adhesions and impaired migration (49), suggesting that successive cycles of phosphorylation/dephosphorylation are required for directed cell migration and that PKA may also be involved in this process.

We hypothesize that the defects observed in mesodermal derivatives result from antagonism of growth factor-mediated production and migration of mesoderm out of the primitive streak. The fact that we can incrementally rescue all the mesodermal derivatives of the primitive streak by reducing the total amount of C subunit supports the hypothesis that excessive catalytic subunit activity is antagonizing growth factor signaling in the primitive streak. These observations support a model in which PKA plays a role as a general negative regulator of growth factor signaling in the primitive streak, not unlike its role as a general negative regulator of sonic hedgehog signaling in vertebrates (19, 20). Whether the cAMP/PKA pathway is normally involved in regulating receptor tyrosine kinase signaling in the primitive streak via endogenous G-protein-coupled receptors remains to be demonstrated.

Is there a specific role for RIalpha in mouse embryo development? C